The A62V and S68G Mutations in HIV-1 Reverse Transcriptase Partially Restore the Replication Defect Associated With the K65R Mutation-Reference-Cited by-同舟云学术

The A62V and S68G Mutations in HIV-1 Reverse Transcriptase Partially Restore the Replication Defect Associated With the K65R Mutation

Published:2008-08-01 Issue:4 Volume:48 Page:428-436
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Svarovskaia Evguenia S,Feng Joy Y,Margot Nicolas A,Myrick Florence,Goodman Derrick,Ly John K,White Kirsten L,Kutty Nilima,Wang Ruth,Borroto-Esoda Katyna,Miller Michael D

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference42 articles.

1. Resistance to protease inhibitors.;Kuritzkes;J HIV Ther,2002

2. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.;Gallant;JAMA,2004

3. Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1.;Garcia-Lerma;J Virol,2000

4. Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group.;Harrigan;J Infect Dis,2000

5. Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF.;Margot;AIDS,2002

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of first-line ART regimens based on tenofovir in HIV-infected patients with pre-existing A62V mutation in reverse transcriptase;Problems of Virology;2024-07-05

2. The role of HIV-1 polymorphism in the pathogenesis of the disease;HIV Infection and Immunosuppressive Disorders;2023-10-21

3. HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes;Viruses;2023-09-25

4. HIV-1 resistance to islatravir/tenofovir combination therapy in wild-type or NRTI resistant strains of diverse HIV-1 subtypes;2023-06-18

5. Antiviral activity of tenofovir alafenamide (TAF) against HIV‐1 clinical isolates harboring K65R;Journal of Medical Virology;2023-04